Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis.

@article{Denderen2014AdalimumabSR,
  title={Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis.},
  author={J. Christiaan van Denderen and Ingrid M Visman and Michael T. Nurmohamed and Maria S. A. Suttorp-Schulten and Irene Eva van der Horst-Bruinsma},
  journal={The Journal of rheumatology},
  year={2014},
  volume={41 9},
  pages={1843-8}
}
OBJECTIVE To investigate whether use of adalimumab decreases the frequency of attacks of anterior uveitis (AU) in patients with ankylosing spondylitis (AS). METHODS Consecutive patients with AS, visiting an outpatient clinic and treated for at least 12 weeks with adalimumab, were enrolled. The number of attacks of AU in the year before start and during treatment were assessed by patient history and ophthalmological controls. RESULTS In the 77 patients a total of 52 AU attacks occurred in… CONTINUE READING